
Opinion|Videos|February 5, 2024
How to Address Increasing Neurofilament Light Chain Levels
Tanuja Chitnis, MD, shares possible course of action if NFL levels begin to rise during treatment.
Advertisement
Episodes in this series

Tanuja Chitnis, MD, expresses a preference for conducting an MRI and personally examining the patient to gather a comprehensive understanding of the situation. She emphasizes the need to identify potential asymptomatic new changes on the neurological exam. Additionally, she acknowledges that the level of comfort and confidence in interpreting NFL changes may evolve in the future.
Video synopsis is AI-generated and reviewed by HCPLive® editorial staff.
This program is supported by Novartis Pharmaceuticals Corporation. Content is independently developed by CMSC.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 Biomarker Data Shows Valiltramiprosate Reduces Plasma p-Tau217 in APOE4/4 Carriers
2
AAIC 2026 Preview: David Wolk, MD, on Biomarkers, Disease Heterogeneity, and What's Next in Alzheimer Research
3
Rethinking Clinical Trial Design and the Immune System in Multiple Sclerosis: Ahmed Obeidat, MD, PhD
4
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment
5



















